FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Matthew J. Zirwas, MD
- Other Dermatitis
Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
Peter Lio, MD
Christy Chang, BA
Ronald Prussick, MD
